Profil
Stuart Kupfer is Senior Vice President-Clinical Development at Cytokinetics, Inc. since 2026.
Formerly, Dr. Kupfer was Vice President & Head-Therapeutic Area at Takeda Pharmaceuticals U.S.A., Inc. from 2004 to 2016.
Dr. Kupfer also worked at the University of Washington.
Dr. Kupfer earned a doctorate from the University of Florida.
Aktive Positionen von Stuart Kupfer
| Unternehmen | Position | Beginn |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 |
Ehemalige bekannte Positionen von Stuart Kupfer
| Unternehmen | Position | Ende |
|---|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | 01.01.2016 |
Ausbildung von Stuart Kupfer
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Cytokinetics, Inc.
Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
University of Florida
University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
















